Walleye Capital
BIO icon

Walleye Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Walleye Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,200
Closed -$1.97M – 5303
2024
Q2 		$1.97M Buy
7,200
+6,900
+2,300% +$2.01M ﹤0.01% 2120
2024
Q1 		$104K Sell
300
-2,100
-88% -$691K ﹤0.01% 4377
2023
Q4 		$775K Buy
+2,400
New +$752K ﹤0.01% 2592
2020
Q1 		– Sell
-500
Closed -$185K – 959
2019
Q4 		$185K Hold
500
– – 0.01% 1144
2019
Q3 		$166K Hold
500
– – 0.01% 1266
2019
Q2 		$156K Buy
+500
New +$150K 0.02% 1064

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return